These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19929137)

  • 1. Application of proteomics in biomarker discovery: a primer for the clinician.
    Tambor V; Fučíková A; Lenco J; Kacerovský M; Řeháček V; Stulík J; Pudil R
    Physiol Res; 2010; 59(4):471-497. PubMed ID: 19929137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Candidate Biomarkers.
    Wiktorowicz JE; Soman KV
    Adv Exp Med Biol; 2016; 919():443-462. PubMed ID: 27975230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.
    Kolarcik C; Bowser R
    Mol Diagn Ther; 2006; 10(5):281-92. PubMed ID: 17022691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted and Untargeted Proteomics Approaches in Biomarker Development.
    Sobsey CA; Ibrahim S; Richard VR; Gaspar V; Mitsa G; Lacasse V; Zahedi RP; Batist G; Borchers CH
    Proteomics; 2020 May; 20(9):e1900029. PubMed ID: 31729135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology tools: proteomics techniques in biomarker discovery.
    Lottspeich F; Kellermann J; Keidel EM
    Scand J Clin Lab Invest Suppl; 2010; 242():19-22. PubMed ID: 20515271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.
    Sabherwal S; English JA; Föcking M; Cagney G; Cotter DR
    Expert Rev Proteomics; 2016 Dec; 13(12):1141-1155. PubMed ID: 27771981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry.
    Cominetti O; Núñez Galindo A; Corthésy J; Oller Moreno S; Irincheeva I; Valsesia A; Astrup A; Saris WH; Hager J; Kussmann M; Dayon L
    J Proteome Res; 2016 Feb; 15(2):389-99. PubMed ID: 26620284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum proteomics in biomedical research: a systematic review.
    Zhang AH; Sun H; Yan GL; Han Y; Wang XJ
    Appl Biochem Biotechnol; 2013 Jun; 170(4):774-86. PubMed ID: 23609910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.
    Greco V; Piras C; Pieroni L; Urbani A
    Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery.
    Lee PY; Osman J; Low TY; Jamal R
    Bioanalysis; 2019 Oct; 11(19):1799-1812. PubMed ID: 31617391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches in kidney disease biomarker discovery.
    Fenton RA
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1817-F1821. PubMed ID: 30230371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.
    Butt AQ; McArdle A; Gibson DS; FitzGerald O; Pennington SR
    Curr Rheumatol Rep; 2015 May; 17(5):35. PubMed ID: 25895652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?
    Kessel C; McArdle A; Verweyen E; Weinhage T; Wittkowski H; Pennington SR; Foell D
    Curr Rheumatol Rep; 2018 Jul; 20(9):53. PubMed ID: 30008153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
    Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
    Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma-derived microparticles for biomarker discovery.
    Smalley DM; Ley K
    Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward an integrated pipeline for protein biomarker development.
    Drabovich AP; Martínez-Morillo E; Diamandis EP
    Biochim Biophys Acta; 2015 Jun; 1854(6):677-86. PubMed ID: 25218201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the development of plasma protein biomarkers.
    Surinova S; Schiess R; Hüttenhain R; Cerciello F; Wollscheid B; Aebersold R
    J Proteome Res; 2011 Jan; 10(1):5-16. PubMed ID: 21142170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.